144 related articles for article (PubMed ID: 12230620)
21. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
[TBL] [Abstract][Full Text] [Related]
22. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer.
Yu H; Bharaj B; Vassilikos EJ; Giai M; Diamandis EP
Breast Cancer Res Treat; 2000 Jan; 59(2):153-61. PubMed ID: 10817350
[TBL] [Abstract][Full Text] [Related]
23. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
[TBL] [Abstract][Full Text] [Related]
24. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer.
Lange EM; Chen H; Brierley K; Livermore H; Wojno KJ; Langefeld CD; Lange K; Cooney KA
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):439-42. PubMed ID: 10794490
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor CAG repeats and prostate cancer.
Nelson KA; Witte JS
Am J Epidemiol; 2002 May; 155(10):883-90. PubMed ID: 11994226
[TBL] [Abstract][Full Text] [Related]
26. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines.
Beilin J; Ball EM; Favaloro JM; Zajac JD
J Mol Endocrinol; 2000 Aug; 25(1):85-96. PubMed ID: 10915221
[TBL] [Abstract][Full Text] [Related]
27. Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues.
Sircar K; Gottlieb B; Alvarado C; Aprikian A; Beitel LK; Alam-Fahmy M; Begin L; Trifiro M
Prostate Cancer Prostatic Dis; 2007; 10(4):360-8. PubMed ID: 17440439
[TBL] [Abstract][Full Text] [Related]
28. The relationship between the androgen receptor CAG repeat polymorphism length and the response to intermittent androgen suppression therapy for advanced prostate cancer.
Klotz L; Correia A; Zhang W
Prostate Cancer Prostatic Dis; 2005; 8(2):179-83. PubMed ID: 15809670
[TBL] [Abstract][Full Text] [Related]
29. CAG polymorphic repeat lengths in androgen receptor gene among Japanese prostate cancer patients: potential predictor of prognosis after endocrine therapy.
Suzuki H; Akakura K; Komiya A; Ueda T; Imamoto T; Furuya Y; Ichikawa T; Watanabe M; Shiraishi T; Ito H
Prostate; 2002 May; 51(3):219-24. PubMed ID: 11967956
[TBL] [Abstract][Full Text] [Related]
30. A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects.
Beilin J; Harewood L; Frydenberg M; Mameghan H; Martyres RF; Farish SJ; Yue C; Deam DR; Byron KA; Zajac JD
Cancer; 2001 Aug; 92(4):941-9. PubMed ID: 11550169
[TBL] [Abstract][Full Text] [Related]
31. [CAG microsatellite polymorphisms of androgen receptor gene and the stage and grade of prostate cancer].
Li C; Dong J; Guan W
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):217-9. PubMed ID: 11783090
[TBL] [Abstract][Full Text] [Related]
32. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
[TBL] [Abstract][Full Text] [Related]
33. Polymorphic repeats in the androgen receptor gene in high-risk sibships.
Miller EA; Stanford JL; Hsu L; Noonan E; Ostrander EA
Prostate; 2001 Aug; 48(3):200-5. PubMed ID: 11494335
[TBL] [Abstract][Full Text] [Related]
34. The place of androgen receptor gene mutation analysis in the molecular diagnosis of prostate cancer and genotype-phenotype relationship.
Kizilay F; Kalemci MS; Şimşir A; Turna B; Nazli O; Berdeli A
Turk J Med Sci; 2014; 44(2):261-6. PubMed ID: 25536734
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the effects of androgen receptor gene trinucleotide repeats and prostate-specific antigen gene polymorphisms on prostate cancer.
Alptekin D; Izmirli M; Bayazit Y; Luleyap HU; Yilmaz MB; Soyupak B; Erkoc MA; Tansug Z
Genet Mol Res; 2012 May; 11(2):1424-32. PubMed ID: 22653589
[TBL] [Abstract][Full Text] [Related]
36. Positive association of the androgen receptor CAG repeat length polymorphism with the risk of prostate cancer.
Paz-Y-Miño C; Robles P; Salazar C; Leone PE; García-Cárdenas JM; Naranjo M; López-Cortés A
Mol Med Rep; 2016 Aug; 14(2):1791-8. PubMed ID: 27357524
[TBL] [Abstract][Full Text] [Related]
37. The androgen receptor CAG repeat: a modifier of carcinogenesis?
Ferro P; Catalano MG; Dell'Eva R; Fortunati N; Pfeffer U
Mol Cell Endocrinol; 2002 Jul; 193(1-2):109-20. PubMed ID: 12161010
[TBL] [Abstract][Full Text] [Related]
38. GGN repeat length and GGN/CAG haplotype variations in the androgen receptor gene and prostate cancer risk in south Indian men.
Vijayalakshmi K; Thangaraj K; Rajender S; Vettriselvi V; Venkatesan P; Shroff S; Vishwanathan KN; Paul SFD
J Hum Genet; 2006; 51(11):998-1005. PubMed ID: 16969583
[TBL] [Abstract][Full Text] [Related]
39. CAG repeat length in the androgen receptor gene is enhanced in patients with idiopathic azoospermia.
Yoshida KI; Yano M; Chiba K; Honda M; Kitahara S
Urology; 1999 Dec; 54(6):1078-81. PubMed ID: 10604712
[TBL] [Abstract][Full Text] [Related]
40. Role of an androgen receptor gene polymorphism in development of hormone refractory prostate cancer in Indian population.
Mittal RD; Mishra D; Mandhani AK
Asian Pac J Cancer Prev; 2007; 8(2):275-8. PubMed ID: 17696745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
